Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.53 INR | -0.11% | -4.04% | +12.24% |
Apr. 03 | GlobalSpace Technologies Limited Announces Resignation of Amit Verma, Executive Director | CI |
Mar. 08 | Globalspace Technologies to Buy 51% Stake in Innopharm Healthcare | MT |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 698.9 | 698.9 | 573.4 | 692 | 582 | 693.1 |
Enterprise Value (EV) 1 | 651.8 | 738.8 | 648.1 | 773.2 | 863.1 | 930.1 |
P/E ratio | 27.4 x | 61 x | 17.8 x | 12.2 x | 106 x | 66.7 x |
Yield | - | - | - | 0.33% | - | - |
Capitalization / Revenue | 2.39 x | 4.56 x | 2.21 x | 2.55 x | 4.38 x | 3.58 x |
EV / Revenue | 2.23 x | 4.82 x | 2.5 x | 2.85 x | 6.5 x | 4.81 x |
EV / EBITDA | 14.9 x | 25.6 x | 11.7 x | 8.66 x | 16.3 x | 21.9 x |
EV / FCF | -13 x | 118 x | -10.3 x | 15.9 x | -4.68 x | 49 x |
FCF Yield | -7.71% | 0.85% | -9.71% | 6.3% | -21.4% | 2.04% |
Price to Book | 2.15 x | 2.08 x | 1.72 x | 1.94 x | 1.65 x | 0.96 x |
Nbr of stocks (in thousands) | 11,457 | 11,457 | 11,457 | 11,457 | 11,457 | 22,913 |
Reference price 2 | 61.00 | 61.00 | 50.05 | 60.40 | 50.80 | 30.25 |
Announcement Date | 8/4/18 | 9/3/19 | 12/7/20 | 10/23/21 | 9/7/22 | 9/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 291.8 | 153.4 | 259.1 | 270.9 | 132.9 | 193.4 |
EBITDA 1 | 43.63 | 28.87 | 55.4 | 89.27 | 53.05 | 42.41 |
EBIT 1 | 41.37 | 26.25 | 52.25 | 79.39 | 24.68 | 25.33 |
Operating Margin | 14.18% | 17.11% | 20.16% | 29.31% | 18.57% | 13.1% |
Earnings before Tax (EBT) 1 | 33.89 | 19.96 | 43.61 | 71.92 | 9.313 | 4.967 |
Net income 1 | 23.21 | 11.49 | 32.14 | 56.56 | 5.541 | 5.195 |
Net margin | 7.95% | 7.49% | 12.4% | 20.88% | 4.17% | 2.69% |
EPS 2 | 2.226 | 1.000 | 2.806 | 4.937 | 0.4800 | 0.4534 |
Free Cash Flow 1 | -50.26 | 6.263 | -62.95 | 48.71 | -184.3 | 18.99 |
FCF margin | -17.22% | 4.08% | -24.29% | 17.98% | -138.69% | 9.82% |
FCF Conversion (EBITDA) | - | 21.69% | - | 54.56% | - | 44.78% |
FCF Conversion (Net income) | - | 54.49% | - | 86.12% | - | 365.53% |
Dividend per Share | - | - | - | 0.2000 | - | - |
Announcement Date | 8/4/18 | 9/3/19 | 12/7/20 | 10/23/21 | 9/7/22 | 9/6/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 40 | 74.7 | 81.3 | 281 | 237 |
Net Cash position 1 | 47.1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 1.384 x | 1.349 x | 0.9103 x | 5.299 x | 5.587 x |
Free Cash Flow 1 | -50.3 | 6.26 | -62.9 | 48.7 | -184 | 19 |
ROE (net income / shareholders' equity) | 10.9% | 3.48% | 9.34% | 17.3% | 1.94% | 1.45% |
ROA (Net income/ Total Assets) | 7.39% | 3.72% | 8.06% | 10.2% | 2.54% | 2.44% |
Assets 1 | 314 | 308.5 | 398.7 | 552.7 | 218.4 | 213.2 |
Book Value Per Share 2 | 28.30 | 29.30 | 29.10 | 31.10 | 30.80 | 31.50 |
Cash Flow per Share 2 | 8.310 | 0.3800 | 0.1400 | 1.930 | 0.0300 | 0.0100 |
Capex 1 | 92 | 25.8 | 32.3 | 83.4 | 145 | 7.35 |
Capex / Sales | 31.53% | 16.79% | 12.46% | 30.78% | 109.34% | 3.8% |
Announcement Date | 8/4/18 | 9/3/19 | 12/7/20 | 10/23/21 | 9/7/22 | 9/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+12.24% | 10.16M | |
+17.69% | 3,289B | |
+14.62% | 90.43B | |
+14.59% | 85.57B | |
+37.27% | 52.49B | |
-19.27% | 50.25B | |
+32.93% | 46.79B | |
+83.75% | 42.74B | |
-32.70% | 41.67B | |
-1.24% | 27.82B |
- Stock Market
- Equities
- GSTL6 Stock
- Financials GlobalSpace Technologies Limited